Ignite Creation Date:
2025-12-24 @ 2:51 PM
Ignite Modification Date:
2026-03-09 @ 4:15 AM
Study NCT ID:
NCT00091559
Status:
COMPLETED
Last Update Posted:
2017-04-05
First Post:
2004-09-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Oral SAHA (Suberoylanilide Hydroxamic Acid) in Advanced Cutaneous T-cell Lymphoma (0683-001)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-02-03
Start Date Type:
ACTUAL
Primary Completion Date:
2005-11-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-03-13
Completion Date Type:
ACTUAL
First Submit Date:
2004-09-10
First Submit QC Date:
None
Study First Post Date:
2004-09-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-03
Last Update Post Date:
2017-04-05
Last Update Post Date Type:
ACTUAL